A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: ER-positive, HER2-negative Breast Cancer
Interventions: DRUG: [14C]AZD9833 Oral Solution, 75 mg
Sponsor: AstraZeneca
Collaborators: Quotient Sciences